نتائج البحث 161-170 من 4729 لعملية البحث عن Blood factor II
To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase 3 clinical trials for patients with ...
The second objective is to continue to identify whether there is a genetic link associated with MacTel Type 2. All participants who have not previously provided ...
The purpose of this study is to determine if DNA originating from the transplanted heart or lung can be detected in the blood and used to monitor for rejection.
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
In addition, two breathing tests will also be performed. During this visit, blood is drawn during exercise. If you are a patient at Mayo Clinic, who is ...
... blood flow before and after procedure to destroy the pain sensory nerves of the kidneys in patients with untreatable one or two sided kidney pain. We will ...
... factor receptor 2 negative (ER+/HER2-) advanced ... توجّه للصفحة 22 · توجّه ... In the phase II part, to evaluate the preliminary antitumor activity of two ...
One of these medicines, bevacizumab, blocks blood vessel growth. It has shown benefit for some people with growing vestibular schwannomas. In studies, it ...
prior chemotherapy or radiation exposure, cumulative radiotheranostic dose) with geneticclonal abnormalities (blood-based CHIP panel) in studying the ...
... (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in PRRT-treated neuroendocrine tumor ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.